Title : Silibinin reverses drug resistance in human small-cell lung carcinoma cells.

Pub. Date : 2013 Oct 1

PMID : 23879966






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pre-incubation of VPA17 cells in 30 muM silibinin for 5 days also reversed resistance to etoposide (IC50 = 5.50 to 0.65 muM) and doxorubicin (IC50 = 0.625 to 0.035 muM). Etoposide latexin Homo sapiens
2 Pre-incubation of VPA17 cells in 30 muM silibinin for 5 days also reversed resistance to etoposide (IC50 = 5.50 to 0.65 muM) and doxorubicin (IC50 = 0.625 to 0.035 muM). Etoposide latexin Homo sapiens
3 Pre-incubation of VPA17 cells in 30 muM silibinin for 5 days also reversed resistance to etoposide (IC50 = 5.50 to 0.65 muM) and doxorubicin (IC50 = 0.625 to 0.035 muM). Etoposide latexin Homo sapiens